China ADVATE PTP Study

PHASE4CompletedINTERVENTIONAL
Enrollment

82

Participants

Timeline

Start Date

June 26, 2014

Primary Completion Date

May 31, 2016

Study Completion Date

May 31, 2016

Conditions
Hemophilia A
Interventions
BIOLOGICAL

Octocog alfa (recombinant human coagulation factor VIII)

"* Part 1: Pharmacokinetic (PK) analysis - Subset of 24 participants~* Part 2: On-demand treatment regimen~* Part 3: Prophylaxis treatment regimen"

Trial Locations (11)

100045

Beijing Children's Hospital Affiliated to Capital University of Medical Sciences, Beijing

100730

Peking Union Medical College Hospital, Dongcheng

200025

Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai

215006

The First Affiliated Hospital of Soochow University, Suzhou

300020

Hospital of Blood Disease, Chinese Academy of Medical Sciences, Tianjin

310003

The First Affiliated Hospital of College of Medicine, Zhengjiang University, Hangzhou

350001

Fujian Medical University Union Hospital, Fuzhou

410008

Xiangya Hospital Central South University, Changsha

430022

Tongji Hosp, Tongji Med. Col, Huazhong Univ. of Sci. & Tech/ Wuhan Union Hospital, Wuhan

430030

Tongji Hospital of Tongji Medical College of Hongzhong Science and Techology University, Wuhan

061001

Cangzhou Central Hospital, Cangzhou

All Listed Sponsors
lead

Baxalta now part of Shire

INDUSTRY

NCT02170402 - China ADVATE PTP Study | Biotech Hunter | Biotech Hunter